Novartis AG (NVS)
Healthcare
- CEO
- Vasant Narasimhan
- Headquarters
- United States
- Employees
- 75,267
- Market Cap
- $301.9B
About Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
SentiSense also tracks daily options readings for Novartis AG: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Novartis AG stock analysis, sentiment tracking, and market intelligence on SentiSense.